Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Overview of attention for article published in AIDS Research and Human Retroviruses, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,928 followers.

RT @HopkinsCFAR: #HopkinsCFAR member Leah Rubin, et al. share results:"In women living with HIV who were not obese, switching to antiretrov…

#HopkinsCFAR member Leah Rubin, et al. share results:"In women living with HIV who were not obese, switching to antiretroviral medicines including integrase inhibitors and tenofovir alafenamide was associated with significant gains in body weight and BM…

New @MACSWIHSCCS publication! In a study of women living with #HIV, a team feat. #EmoryCFAR Members found that #weight & body mass index change after switching to integrase inhibitors (INSTIs) and/or tenofovir alafenamide (TAF). Learn more: https://…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.